Search Results

Following the national procurement for medical retinal vascular medicines, NHS England has published an operational note on Commissioning recommendations. This followed discussions with various stakeholders, including members of The Royal College of Ophthalmologists. It introduces the use of ranibizumab biosimilars alongside available intravitreal anti-VEGF agents and steroids in the treatment algorithms for wet age-related macular degeneration, […]

COVID-19 has led to a national lockdown in the New Year with increased infection rates putting immense pressure on frontline services which has meant the redeployment of ophthalmic staff, including ophthalmologists in training is already taking place.

We are republishing the statement from the Academy of Medical Royal Colleges on the COVID-19 Vaccination and second doses.

The new RCOphth Strategic Plan 2020-2022 directs and prioritises key policy and campaign activities over the next three years. The way NHS care is provided and the treatments available to improve patients’ lives have changed almost beyond recognition since our charter first set out our obligations as a medical royal college in 1988.

The Royal College of Ophthalmologists champions excellence in the practice of ophthalmology. We are the only professional membership body for medically qualified ophthalmologists and for those who are undergoing specialist training to become ophthalmologists.

Guidance for commissioners/ integrated care boards, providers, social care, charitable organisations and users of the age-related macular degeneration (AMD) services, including their families and carers.